Results 221 to 230 of about 42,337 (292)

CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes

, 1995
Yoo Hong Min, Seung‐Tae Lee, Dong Won Min, Tai Seung Kim, Chan Hee Lee, Byoung Kwon Lee, Jee Sook Hahn, Yun Woong Ko   +7 more
openalex   +1 more source

Frequency and Relevance of MYD88L256P Mutation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy

European Journal of Neurology, Volume 32, Issue 8, August 2025.
MYD88L256P mutation was searched in 79 CIDP, 35 MMN, and 57 controls. It was more frequent in MMN (34%) and CIDP (19%) than in controls (2%). It suggests new pathophysiological hypotheses and new therapeutic approaches for chronic inflammatory neuropathies.
Alexandre Guérémy, John Boudjarane, Emilie Alazard, Etienne Fortanier, José Boucraut, Norman Abbou, Aude‐Marie Grapperon, Ludivine Kouton, Annie Verschueren, Emmanuelle Salort‐Campana, Shahram Attarian, Emilien Delmont   +11 more
wiley   +1 more source

Allogeneic Stem Cell Transplant for Myelofibrosis and Myelodysplastic Syndromes: A Contemporary Review. [PDF]

Am J Hematol
Gagelmann N, Kröger N.
europepmc   +1 more source

Cytogenetic study of 50 Brazilian patients with primary myelodysplastic syndrome

, 1997
Teresa de Souza Fernandez, Maria Luíza M. Silva, Jamison Menezes de Souza, Daniel Tabak, Eliana Abdelhay   +4 more
openalex   +1 more source

The TP53 tumor suppressor gene: From molecular biology to clinical investigations

Journal of Internal Medicine, Volume 298, Issue 2, Page 78-96, August 2025.
Abstract Extensively studied over the past four decades, the TP53 gene has emerged as a pivotal watchman in cellular defense and a key factor in cancer biology. TP53 is the most frequently mutated gene in human malignancies, 50% of which carry alterations to it.
Panagiotis Baliakas, Thierry Soussi
wiley   +1 more source

Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes. [PDF]

Sci Rep
Bertolini A, Picone F, Ferrara I, Della Corte AM, Serio B, Gorrese M, Campana A, Simeon V, Luponio S, Marcucci R, Scala P, Langella M, Selleri C, Giudice V.   +13 more
europepmc   +1 more source

Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient

Pediatric Transplantation, Volume 29, Issue 5, August 2025.
ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) in solid organ transplant recipients has been reported in adults. However, data on children are scarce. We report a case of an allogeneic HSCT in a 14‐year‐old girl to treat idiopathic very severe aplastic anemia (SAA). Case Presentation The girl developed end‐stage renal disease at the
Gintarė Mierkienė, Goda Elizabeta Vaitkevičienė, Karolis Ažukaitis, Augustina Jankauskienė, Jelena Rascon   +4 more
wiley   +1 more source

Experiences with Higher-Risk Myelodysplastic Syndromes and Improving Patient-Centered Treatment Decision-Making: A Qualitative Study of Patients, Caregivers, and Providers. [PDF]

Cancer Manag Res
Maravic MC, Land N, Prood N, Cagle C, May SG, Batt K, Sabate EJ, Afulezi N, Jhaveri TZ, Iraca T, Hogea C.   +10 more
europepmc   +1 more source

Application of the International Prognostic Scoring System for myelodysplastic syndromes

, 1999
Brigitte Maes, Mira Meeus, Lucienne Michaux, Luc Bijnens, M. A. Boogaerts, A Hagemeijer, Chris De Wolf‐Peeters, G. Verhoef   +7 more
openalex   +1 more source